Infectious keratitis is mainly treated with topical antibiotics. To achieve and maintain the required therapeutic concentration in the cornea where the tear fluid continuously rinses the surface, the antibiotics must be frequently applied, even while the patient is sleeping, and oral medication is sometimes required. However, the inevitably poor compliance and avascular nature of the cornea decrease drug bioavailability. In this study, a single microneedle (MN) is injected into the cornea to substitute for the repeated application of eyedrops in the treatment of infectious keratitis. After comparing the mechanical integrity and drug release profiles of three different drug-tips, the drug-tip with the “high” drug concentration that releases 12.5 ng drug within 3 days is applied to a cornea to evaluate the transferability and in vivo drug release. In the treatment of infectious keratitis with repeated application of eyedrops for six consecutive days, a single MN injection is substituted for the initial 3 days of eyedrop applications. The progression remains similarly attenuated after 3 days without eyedrops, and comparable efficacy is achieved on day 6 when combined with delayed eyedrop treatment from day 3. Thus, the single administration of a biodegradable MN can substitute for the repeated application of eyedrops in the treatment of infectious keratitis.
Bibliographical noteFunding Information:
S.P., K.J.L., and H.K. contributed equally to this work. This work was supported by Grant No. 04‐2018‐0380 from the SNUH Research Fund, Research Resettlement Fund for the new faculty of Seoul National University, the National Research Foundation of Korea (NRF) Grant funded by the Ministry of Science and ICT (MSIT) (2015R1A5A1037668), and Global Infrastructure Program through the NRF funded by the MSIT (2019K1A3A1A18116048).
© 2021 Wiley-VCH GmbH
All Science Journal Classification (ASJC) codes
- Biomedical Engineering
- Pharmaceutical Science